- Home
- ICG vs THTX Comparison
ICG vs THTX Comparison
Compare ICG & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICG
- THTX
- Stock Information
- Founded
- ICG 2017
- THTX 1993
- Country
- ICG China
- THTX Canada
- Employees
- ICG N/A
- THTX N/A
- Industry
- ICG Semiconductors
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- ICG Technology
- THTX Health Care
- Exchange
- ICG Nasdaq
- THTX Nasdaq
- Market Cap
- ICG 105.7M
- THTX 119.1M
- IPO Year
- ICG 2023
- THTX N/A
- Fundamental
- Price
- ICG $2.80
- THTX $3.15
- Analyst Decision
- ICG Strong Buy
- THTX Hold
- Analyst Count
- ICG 2
- THTX 1
- Target Price
- ICG $9.25
- THTX N/A
- AVG Volume (30 Days)
- ICG 351.4K
- THTX 1.0M
- Earning Date
- ICG 08-14-2025
- THTX 07-09-2025
- Dividend Yield
- ICG N/A
- THTX N/A
- EPS Growth
- ICG N/A
- THTX N/A
- EPS
- ICG 0.07
- THTX N/A
- Revenue
- ICG $53,729,346.00
- THTX $84,378,000.00
- Revenue This Year
- ICG N/A
- THTX N/A
- Revenue Next Year
- ICG $141.94
- THTX $15.13
- P/E Ratio
- ICG $38.55
- THTX N/A
- Revenue Growth
- ICG 384.54
- THTX 2.19
- 52 Week Low
- ICG $1.19
- THTX $1.12
- 52 Week High
- ICG $12.04
- THTX $3.20
- Technical
- Relative Strength Index (RSI)
- ICG 66.82
- THTX 73.35
- Support Level
- ICG $1.75
- THTX $2.28
- Resistance Level
- ICG $2.79
- THTX $3.20
- Average True Range (ATR)
- ICG 0.38
- THTX 0.07
- MACD
- ICG 0.13
- THTX 0.08
- Stochastic Oscillator
- ICG 89.18
- THTX 94.79
About ICG Intchains Group Limited
Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.